InsidersTradesSigma
Follow the 泽璟制药 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 泽璟制药 has logged 32 insider filings. Market capitalisation: €29.4bn. The latest transaction was filed on 16 April 2026 (Sale). Among the most active insiders: ZELIN SHENG(盛泽林). The full history is openly available.
32
Insider Decl.
n/a
Thresholds
€2m
31 ops.
Buy Volume
€3m
1 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,770 of 29,064 companies
49.7
score / 100
Value33
Quality67
FCF yld-0.7%
Earn yld-0.5%
EV/EBITDA·
ROE38%
Gross mgn90%
Net mgn-20%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 April 2026
Declarations32 total
273,907 sharesA股XSHGSSE:273000000422970880
1,784 sharesA股XSHGSSE:173000005692962100
200 sharesA股XSHGSSE:173000005662820540
2,079 sharesA股XSHGSSE:173000005659772930
1,050 sharesA股XSHGSSE:173000005649137920
2,360 sharesA股XSHGSSE:173000005649150940
2,000 sharesA股XSHGSSE:173000005547914300
920 sharesA股XSHGSSE:173000005547914780
8,000 sharesA股XSHGSSE:173000005547913570
3,500 sharesA股XSHGSSE:173000005539713440
27,380 sharesA股XSHGSSE:173000005378757300
2,000 sharesA股XSHGSSE:173000005367543580
30,000 sharesA股XSHGSSE:173000005367546620
11,000 sharesA股XSHGSSE:173000005365277760
8,820 sharesA股XSHGSSE:173000005365279170
7,000 sharesA股XSHGSSE:173000005361184800
25 of 32 declarations
Acerca de 泽璟制药
Zai Lab es una empresa centrada en el desarrollo de medicamentos innovadores, particularmente en oncología. Cotiza en la Bolsa de Shanghái.